171 results
Rhabdomyolysis - McMahon risk prediction score

Using this prediction model, patients with a score < 5 were
Rhabdomyolysis - McMahon risk ... prediction score ... Using this prediction ... found to have low risk ... #prediction #score
Since these risk factors are numerous and have different effects on the malignancy risk, it is
Since these risk ... the malignancy risk ... to assess final risk ... malignancy [8](Table ... #Diagnosis #EBM
COMPARISON OF PREDICTION TOOLS FOR PREDICTING TBI IN PEDIATRIC PATIENTS
 - PECARN 
 - CHALICE
COMPARISON OF PREDICTION ... DecisionRules #EBM
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
Simplified PESI Prediction ... Day Mortality #EBM ... #Diagnosis #EM ... #PESI #sPESI #risk
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile Risk ... study-specific risk ... community-associated CDI risk ... Pharmacology #Class #Risk ... #Clostridium #Table
Rewarming Methods in Hypothermia
 • Passive rewarming - Requires adequate patient physiologic mechanisms. Inadequate for more
Low benefit, low risk ... Gastric lavage - Risks ... Peritoneal lavage - Risks ... Thoracic lavage - Risks ... management #treatment #ebm
Point-of-care lung ultrasound for diagnosis of Pneumocystis jirovecii pneumonia: notes from the field
Table 3: Description of
from the field Table ... ultrasound findings #EBM
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table
Summary of All RCTs to Date on Endovascular Therapy for Acute Ischemic Stroke 

#EBM #Neurology #NeuroInterventionalRadiology
Ischemic Stroke #EBM ... #RCT #Summary #Table
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
ASCVD or ASCVD risk ... ASCVD or ASCVD risk ... SGLT2 #inhibitors #EBM ... visualabstract #table